血漿分画製剤の世界市場:アルブミン、免疫グロブリン、血液凝固因子...市場調査レポートについてご紹介

【英文タイトル】Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED IN THE STUDY 18
1.4 CURRENCY AND PRICING 18
1.5 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
2.2 MARKET SIZE ESTIMATION 21
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.4 MARKET SHARE ESTIMATION 24
2.5 KEY DATA FROM SECONDARY SOURCES 24
2.6 KEY DATA FROM PRIMARY SOURCES 25
2.6.1 KEY INDUSTRY INSIGHTS 26
2.7 ASSUMPTIONS FOR THE STUDY 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 32
4.1 GROWTH POTENTIAL OF THE PLASMA FRACTIONATION MARKET 32
4.2 ASIA-PACIFIC PLASMA FRACTIONATION MARKET 33
4.3 PLASMA FRACTIONATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 34
4.4 NORTH AMERICA DOMINATES THE PLASMA FRACTIONATION MARKET DURING THE FORECAST PERIOD 35
4.5 PLASMA FRACTIONATION MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 35
4.6 PLASMA FRACTIONATION MARKET, BY END USER: GEOGRAPHIC MIX 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 PLASMA FRACTIONATION MARKET, BY PRODUCT 38
5.2.2 PLASMA FRACTIONATION MARKET, BY APPLICATION 38
5.2.3 PLASMA FRACTIONATION MARKET, BY END USER 39
5.3 MARKET DYNAMICS 39
5.3.1 MARKET DRIVERS 40
5.3.1.1 Growing use of immunoglobulin in various therapeutic areas 40
5.3.1.2 Rise in aging population worldwide 41
5.3.1.3 Growing prevalence of emphysema and AATD driving the uptake of alpha-1 antitrypsin 42
5.3.2 MARKET RESTRAINTS 42
5.3.2.1 High cost and limited reimbursement 43
5.3.2.2 Stringent government regulations 43
5.3.2.3 Emergence of recombinant alternatives 43
5.3.3 MARKET OPPORTUNITIES 44
5.3.3.1 Increasing number of hemophilic patients 44
5.3.4 MARKET CHALLENGES 44
5.3.4.1 Pricing pressure faced by prominent players in the market 45

6 INDUSTRY INSIGHTS 46
6.1 INTRODUCTION 46
6.2 INDUSTRY TRENDS 46
6.2.1 RISING NEW INDICATIONS FOR PLASMA PRODUCTS 47
6.2.2 RISING ADOPTION OF SCIG 47
6.2.3 GROWING NUMBER OF FRACTIONATOR-OWNED PLASMA COLLECTION CENTERS 47
6.2.4 GROWING FOCUS OF PLASMA FRACTIONATORS TOWARDS MANUFACTURING AND DEVELOPMENT OF RECOMBINANT FACTORS 48
6.2.5 GROWING PLASMA PRODUCTS MARKET IN CHINA 49
6.3 PORTER’S FIVE FORCES ANALYSIS 52
6.3.1 THREAT FROM NEW ENTRANTS 53
6.3.2 THREAT FROM SUBSTITUTES 53
6.3.3 BARGAINING POWER OF SUPPLIERS 53
6.3.4 BARGAINING POWER OF BUYERS 54
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 54
6.4 STRATEGIC BENCHMARKING 55
6.4.1 INCREASING FRACTIONATION CAPACITY AND GEOGRAPHICAL EXPANSIONS TO DRIVE THE MARKET 55

7 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT 57
7.1 INTRODUCTION 58
7.2 ALBUMIN 60
7.3 IMMUNOGLOBULIN 61
7.3.1 INTRAVENOUS IMMUNOGLOBULIN 62
7.3.2 SUBCUTANEOUS IMMUNOGLOBULIN 63
7.3.3 OTHERS 64
7.4 COAGULATION FACTOR CONCENTRATES 66
7.4.1 FACTOR VIII 68
7.4.2 FACTOR IX 69
7.4.3 FACTOR XIII 70
7.4.4 PROTHROMBIN COMPLEX CONCENTRATE 71
7.4.5 VON WILLEBRAND FACTOR (VWF) 72
7.4.6 FIBRINOGEN CONCENTRATES 73
7.5 PROTEASE INHIBITORS 74
7.6 OTHER PLASMA PRODUCTS 75

8 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION 77
8.1 INTRODUCTION 78
8.2 NEUROLOGY 79
8.3 HEMATOLOGY 81
8.4 IMMUNOLOGY 82
8.5 CRITICAL CARE 84
8.6 OTHER APPLICATIONS 85

9 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER 86
9.1 INTRODUCTION 87
9.2 HOSPITALS AND CLINICS 88
9.3 CLINICAL RESEARCH LABORATORIES 90
9.4 ACADEMIC INSTITUTES 91

10 GLOBAL PLASMA FRACTIONATION MARKET, BY GEOGRAPHY 93
10.1 INTRODUCTION 94
10.2 NORTH AMERICA 96
10.2.1 U.S. 100
10.2.2 CANADA 103
10.3 EUROPE 107
10.3.1 GERMANY 111
10.3.2 ITALY 114
10.3.3 SPAIN 117
10.3.4 FRANCE 120
10.3.5 U.K. 123
10.3.6 REST OF EUROPE (ROE) 126
10.4 ASIA-PACIFIC 129
10.4.1 JAPAN 134
10.4.2 CHINA 136
10.4.3 INDIA 140
10.4.4 REST OF ASIA-PACIFIC (ROAPAC) 142
10.5 REST OF THE WORLD (ROW) 146
10.5.1 LATIN AMERICA 148
10.5.2 MIDDLE EAST AND AFRICA 152

11 COMPETITIVE LANDSCAPE 155
11.1 OVERVIEW 155
11.2 MARKET SHARE ANALYSIS 157
11.3 COMPETITIVE SITUATION AND TRENDS 159
11.3.1 EXPANSIONS 159
11.3.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND ALLIANCES 160
11.3.3 NEW PRODUCT LAUNCHES 161
11.3.4 MERGERS AND ACQUISITIONS 162
11.3.5 PRODUCT ACQUISITION 162

12 COMPANY PROFILES 163
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 INTRODUCTION 163
12.2 BAXTER INTERNATIONAL, INC. 164
12.3 OCTAPHARMA AG 167
12.4 BIOTEST 170
12.5 CSL LTD. 173
12.6 GRIFOLS INTERNATIONAL S.A. 176
12.7 KEDRION S.P.A. 179
12.8 LFB 183
12.9 SANQUIN BLOOD SUPPLY FOUNDATION 185
12.10 BIO PRODUCT LABORATORY LTD. (BPL) 187
12.11 CHINA BIOLOGIC PRODUCTS, INC. 188
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

13 APPENDIX 190
13.1 INSIGHTS OF INDUSTRY EXPERTS 190
13.2 AVAILABLE CUSTOMIZATIONS 190
13.3 RELATED REPORTS 191
13.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 192


【レポート販売概要】

■ タイトル:血漿分画製剤の世界市場:アルブミン、免疫グロブリン、血液凝固因子
■ 英文:Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019
■ 発行日:2014年12月16日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-BT-3042
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。